Abstract
Get full access to this article
View all access options for this article.
References
1.
Tannock
IF
,
de Wit
R
,
Berry
WR
,
Horti
J
,
Pluzanska
A
,
Chi
KN
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer . N Engl J Med
2004 ; 351 : 1502 –12 .
2.
de Bono
JS
,
Oudard
S
,
Ozguroglu
M
,
Hansen
S
,
Machiels
J-P
,
Kocak
I
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial . Lancet
2010 ; 376 : 1147 –54 .
3.
de Bono
JS
,
Logothetis
CJ
,
Molina
A
,
Fizazi
K
,
North
S
,
Chu
L
Abiraterone and increased survival in metastatic prostate cancer . N Engl J Med
2011 ; 364 : 1995 –2005 .